Not financial advice. ThetaGrade is educational and informational only. Nothing here is a recommendation to buy or sell any security, and it is not tailored to anyone. Options involve substantial risk; read the OCC Characteristics and Risks of Standardized Options. Past performance does not guarantee future results. Methodology
ARQT government trades
Arcutis Biotherapeutics, Inc. - Common stock. 1 official filed trades since 2025. ARQT rating
Trades are filed weeks after they happen and amounts are reported as ranges. Educational, not financial advice.
Who traded it
| Official | Branch | Buys | Sells | First trade | Latest trade | Latest filing |
|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D-CA | House | 2 | 1 | 2025-12-11 | 2026-05-29 | 2026-06-08 |
Every ARQT trade
| Traded | Filed | Days | Official | Stock | Type | Amount | Owner | |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | 2026-06-08 | 10 | Gilbert Ray Cisneros, Jr. | ARQT Arcutis Biotherapeutics, Inc. - Common stock | BuyOpen | $1K–$15K | Self | Filing ↗ |
| 2026-03-03 | 2026-04-07 | 35 | Gilbert Ray Cisneros, Jr. | ARQT Arcutis Biotherapeutics, Inc. - Common stock | BuyOpen | $1K–$15K | Self | Filing ↗ |
| 2025-12-11 | 2026-01-12 | 32 | Gilbert Ray Cisneros, Jr. | ARQT Arcutis Biotherapeutics, Inc. - Common stock | Partial sell | $1K–$15K | Self | Filing ↗ |
- ARQT Arcutis Biotherapeutics, Inc. - Common stockOpenBuy
$1K–$15K · Self · traded 2026-05-29 · filed 2026-06-08 (10d) · Filing ↗
- ARQT Arcutis Biotherapeutics, Inc. - Common stockOpenBuy
$1K–$15K · Self · traded 2026-03-03 · filed 2026-04-07 (35d) · Filing ↗
- ARQT Arcutis Biotherapeutics, Inc. - Common stockPartial sell
$1K–$15K · Self · traded 2025-12-11 · filed 2026-01-12 (32d) · Filing ↗
3 trades